Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/1998
03/31/1998US5733558 Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same
03/26/1998WO1998012557A1 Therapeutic agent with quantitative consumption marker and method of monitoring therapeutic agent consumption
03/26/1998WO1998012334A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
03/26/1998WO1998012329A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
03/26/1998WO1998012328A2 Human bad polypeptides, encoding nucleic acids and methods of use
03/26/1998WO1998012325A1 Human gtp binding protein gamma-3
03/26/1998WO1998012228A1 Polymers containing polysaccharides such as alginates or modified alginates
03/26/1998WO1998012224A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes
03/26/1998WO1998012220A2 Novel tumor proteins
03/26/1998WO1998012189A1 Method of producing polyphenol-containing compositions
03/26/1998WO1998011923A1 Identification of agents that protect against inflammatory injury to neurons
03/26/1998WO1998011908A1 Combination therapy for treatment of arthritic diseases
03/26/1998WO1998011907A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
03/26/1998WO1998011906A1 Phospholipid drug derivatives
03/26/1998WO1998011897A1 Combination therapy for treatment of psychoses
03/26/1998WO1998011896A1 Combination therapy for reducing the risks associated with cardiovascular disease
03/26/1998WO1998011894A1 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound
03/26/1998WO1998011886A1 Use of inhibitors of retinoic acid activity for wound healing
03/26/1998WO1998011853A1 Composition and method for acceleration of wound and burn healing
03/26/1998WO1998011789A1 Flavonol containing food supplements
03/26/1998WO1998011778A1 Antimicrobial treatment for herpes simplex virus and other infectious diseases
03/26/1998WO1998004280A3 Topical composition containing amino acid in combination with either interferon or thymidine derivatives for treating viral or inflammation diseases
03/26/1998WO1998001159A3 Composition for enhanced uptake of polar drugs from mucosal surfaces
03/26/1998CA2266585A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes
03/26/1998CA2266404A1 Phospholipid drug derivatives
03/26/1998CA2266341A1 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
03/26/1998CA2266339A1 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
03/26/1998CA2265896A1 Identification of agents that protect against inflammatory injury to neurons
03/26/1998CA2265827A1 Combination therapy for reducing the risks associated with cardiovascular disease
03/26/1998CA2265571A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
03/26/1998CA2264542A1 Human gtp binding protein gamma-3
03/26/1998CA2263818A1 Novel tumor proteins
03/26/1998CA2238043A1 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound
03/26/1998CA2236309A1 Use of inhibitors of retinoic acid activity for wound healing
03/25/1998EP0830864A1 Combination therapy for treatment of psychoses
03/25/1998EP0830860A1 Use of PKC inhibitors for the manufacture of a medicament for the treatment of AIDS
03/25/1998EP0830448A1 Continuous selective clonogenic expansion of relatively undifferentiated cells
03/25/1998EP0830381A1 Chitin hydrogels, methods of their production and use
03/25/1998EP0830145A1 Formulations for lipophilic compounds
03/25/1998EP0830143A1 Use of leukemia inhibitory factor and endothelin antagonists
03/25/1998EP0830138A1 Use of fibroblast growth factors to stimulate bone growth
03/25/1998EP0830133A1 Therapeutic composition for arthritis
03/25/1998EP0830130A1 Tnf-alpha converting enzyme
03/24/1998US5731454 Allosteric modifiers of hemoglobin useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood
03/24/1998US5731339 Administering vasodilator; phentolamine mesylate or hydrochloride
03/24/1998US5731319 Antiallergens; antihistamines
03/24/1998US5731312 Administering mixture of dopamine antagonist and prolactin inhibitor
03/24/1998US5731304 Potentiation of temozolomide in human tumour cells
03/24/1998US5731287 Prolactin
03/24/1998US5730975 Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function
03/24/1998US5730964 Method of treating sweat-related conditions
03/24/1998CA2129037C Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers
03/24/1998CA1339775C Antibody 0.5b to hiv-i gp 120 modified with toxic substance
03/24/1998CA1339770C Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction
03/19/1998WO1998011245A1 Sustained delivery device and methods of making and using the same
03/19/1998WO1998011225A2 A novel haemopoietin receptor and genetic sequences encoding same
03/19/1998WO1998011117A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism
03/19/1998WO1998011116A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity
03/19/1998WO1998010798A1 Improved methods for diagnostic imaging using a contrast agent and a vasodilator
03/19/1998WO1998010794A2 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
03/19/1998WO1998010791A1 Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes
03/19/1998WO1998010782A1 Antifungal combination therapy
03/19/1998WO1998010781A1 Means for treating prostate hypertrophy and prostate cancer
03/19/1998WO1998010778A1 INHIBITION OF APOPTOSIS USING INTERLEUKIN-1β-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS
03/19/1998WO1998010769A1 Formulations and methods for providing prolonged local anesthesia
03/19/1998WO1998010765A1 Non-hormonal method of contraception
03/19/1998WO1998010757A2 The use of functional n-methyl-d-aspartate antagonists to ameliorate or prevent aminoglycoside-induced ototoxicity
03/19/1998WO1998010754A1 Fast decomposing pellets
03/19/1998WO1998010746A1 Compositions and methods for topical application of therapeutic agents
03/19/1998WO1998010652A1 NOVEL trpS
03/19/1998WO1998010651A1 Conjugates useful in the treatment of prostate cancer
03/19/1998WO1998010650A1 Method of treating endothelial injury
03/19/1998WO1998006265A3 Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine
03/19/1998WO1998004289A3 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist
03/19/1998DE19637082A1 Schnellzerfallende Pellets Rapidly disintegrating pellets
03/19/1998CA2265933A1 Sustained delivery device and methods of making and using the same
03/19/1998CA2265861A1 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
03/19/1998CA2265561A1 Formulations and methods for providing prolonged local anesthesia
03/19/1998CA2265495A1 Non-hormonal method of contraception
03/19/1998CA2265476A1 Conjugates useful in the treatment of prostate cancer
03/19/1998CA2264938A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity
03/19/1998CA2264825A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism
03/19/1998CA2264541A1 Human protein kinases
03/18/1998EP0829262A2 Use of PKC inhibitors for the manufacture of a medicament for the treatment of sexual dysfunctions
03/18/1998EP0829011A1 Inhibition of amylin release
03/18/1998EP0828831A2 A novel human purinergic p 2u? receptor
03/18/1998EP0828829A1 A gene switch comprising an ecdysone receptor
03/18/1998EP0828515A1 Antibacterial-wound healing compositions and methods for preparing and using same
03/18/1998EP0828514A1 Immunostimulating-wound healing compositions and methods for preparing and using same
03/18/1998EP0828513A2 Combinations for the treatment of parkinsonism containing selective nmda antagonists
03/18/1998EP0828505A1 Use of angiotensin ii type 2 receptor agonists in tissue repair
03/18/1998EP0828492A1 Method for preventing intervention-associated stenosis following non-bypass, invasive interventions
03/18/1998EP0828489A1 Smoking cessation treatments using naltrexone and related compounds
03/18/1998EP0828487A1 Agents for use against parasitic protozoa
03/18/1998EP0828485A1 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
03/18/1998EP0739214B1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
03/18/1998CN1176598A Method and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
03/18/1998CN1176250A HIV protease inhibitors useful for treatment of AIDS
03/18/1998CN1176102A Use of nonpeptide bradykinin antagonists for treatment and prevention of chronic fibrogenetic liver disorders acute liver disorders and complications associated therewith
03/17/1998US5728868 Prodrugs of protein tyrosine kinase inhibitors
1 ... 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 ... 1151